Back to Search
WILLIAM KERN, MD
MD
Internal Medicine Physician
NPI: 1316189467IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
4301102360(MI)
Pediatrics Physician
Pediatrics
Code: 208000000X
4301102360(MI)
Education
WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE
Class of 2009
Research & Publications (20)
Correlation of flow cytometrically determined expression of ZAP-70 using the SBZAP antibody with IgVH mutation status and cytogenetics in 1,229 patients with chronic lymphocytic leukemia.
PMID 19479984·Cytometry B Clin Cytom·2009
8-other
Monitoring of minimal residual disease in acute myeloid leukemia.
PMID 18000811·Cancer·2008
4-observational
Comparison of mRNA abundance quantified by gene expression profiling and percentage of positive cells using immunophenotyping for diagnostic antigens in acute and chronic leukemias.
PMID 17041886·Cancer·2006
4-observational
High-dose cytosine arabinoside in the treatment of acute myeloid leukemia: Review of three randomized trials.
PMID 16721819·Cancer·2006
4-observational
Fluoroquinolone consumption and resistance in haematology-oncology patients: ecological analysis in two university hospitals 1999-2002.
PMID 15574472·J Antimicrob Chemother·2005
8-other
[Quantification of minimal residual disease by multiparameter flow cytometry in acute myeloid leukemia. From diagnosis to prognosis].
PMID 15654545·Med Klin (Munich)·2005
4-observational
Monitoring of minimal residual disease in acute myeloid leukemia.
PMID 16213150·Crit Rev Oncol Hematol·2005
4-observational
Role of gene expression profiling for diagnosing acute leukemias.
PMID 16027103·Rev Clin Exp Hematol·2005
6-review
Detection of t(14;18)(q32;q21) in B-cell chronic lymphocytic leukemia.
PMID 15737042·Arch Pathol Lab Med·2005
8-other
Gene expression profiling as a diagnostic tool in acute myeloid leukemia.
PMID 15287816·Am J Pharmacogenomics·2004
6-review
Four-fold staining including CD45 gating improves the sensitivity of multiparameter flow cytometric assessment of minimal residual disease in patients with acute myeloid leukemia.
PMID 15448667·Hematol J·2004
4-observational
Determination of relapse risk based on assessment of minimal residual disease during complete remission by multiparameter flow cytometry in unselected patients with acute myeloid leukemia.
PMID 15284114·Blood·2004
8-other
Prognostic impact of early response to induction therapy as assessed by multiparameter flow cytometry in acute myeloid leukemia.
PMID 15136215·Haematologica·2004
8-other
Correlation of protein expression and gene expression in acute leukemia.
PMID 12949957·Cytometry B Clin Cytom·2003
4-observational
Detection of minimal residual disease in unselected patients with acute myeloid leukemia using multiparameter flow cytometry for definition of leukemia-associated immunophenotypes and determination of their frequencies in normal bone marrow.
PMID 12801840·Haematologica·2003
8-other
Early blast clearance by remission induction therapy is a major independent prognostic factor for both achievement of complete remission and long-term outcome in acute myeloid leukemia: data from the German AML Cooperative Group (AMLCG) 1992 Trial.
PMID 12393605·Blood·2003
3-trial
Karyotype instability between diagnosis and relapse in 117 patients with acute myeloid leukemia: implications for resistance against therapy.
PMID 12357361·Leukemia·2002
8-other
Carboplatin pharmacokinetics in patients receiving carboplatin and paclitaxel/docetaxel for advanced lung cancers: impact of age and renal function on area under the curve.
PMID 11206274·J Cancer Res Clin Oncol·2001
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1105 SIXTH ST
TRAVERSE CITY, MI 49684 - Phone
- (231) 922-9270
Quick Facts
- NPI
- 1316189467
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 17
- Publications
- 20
Are you this provider?
Claim Your Profile